243 related articles for article (PubMed ID: 15582127)
1. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
3. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
Hu ZW; Guo JW; Deng XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
[TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.
Yilmaz Y; Alahdab YO; Yonal O; Kurt R; Kedrah AE; Celikel CA; Ozdogan O; Duman D; Imeryuz N; Avsar E; Kalayci C
Metabolism; 2010 Sep; 59(9):1327-30. PubMed ID: 20096896
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
8. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension.
Sorrentino P; Terracciano L; D'Angelo S; Ferbo U; Bracigliano A; Vecchione R
Am J Gastroenterol; 2010 Feb; 105(2):336-44. PubMed ID: 19861959
[TBL] [Abstract][Full Text] [Related]
9. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
[TBL] [Abstract][Full Text] [Related]
10. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE
J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229
[TBL] [Abstract][Full Text] [Related]
11. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
12. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K
Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
[TBL] [Abstract][Full Text] [Related]
14. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
Adams LA; Sanderson S; Lindor KD; Angulo P
J Hepatol; 2005 Jan; 42(1):132-8. PubMed ID: 15629518
[TBL] [Abstract][Full Text] [Related]
15. Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver.
Serin E; Ozer B; Gümürdülü Y; Kayaselçuk F; Kul K; Boyacioğlu S
J Gastroenterol; 2003; 38(5):471-6. PubMed ID: 12768390
[TBL] [Abstract][Full Text] [Related]
16. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
17. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
18. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
19. Plasma apelin levels in subjects with nonalcoholic fatty liver disease.
Ercin CN; Dogru T; Tapan S; Kara M; Haymana C; Karadurmus N; Karslioglu Y; Acikel C
Metabolism; 2010 Jul; 59(7):977-81. PubMed ID: 20045153
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
